Core-binding Factor Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Core-binding Factor Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-04-19Clinical Trial Update: Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia [Phase 1]
A Phase 1 study of dasatinib in combination with chemotherapy for relapsed or refractory core-binding factor acute myeloid leukemia has been…